Literature DB >> 16987934

The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis.

Judit Laki1, István Laki, Krisztina Németh, Rita Ujhelyi, Olga Bede, Emoke Endreffy, Katalin Bolbás, Kálmán Gyurkovits, Eszter Csiszér, Eniko Sólyom, Gergely Dobra, Adrienn Halász, Eva Pozsonyi, Katalin Rajczy, Zoltán Prohászka, György Fekete, George Füst.   

Abstract

Major cause of death in patients with cystic fibrosis (CF) is colonization with Staphylococcus aureus and Pseudomonas aeruginosa. The wide phenotypic variation in CF patients suggests that genes other than the cystic fibrosis transmembrane conductance regulator (CFTR) gene modify the disease. The 8.1 ancestral haplotype (8.1AH) in main histocompatibility complex is associated with alterations of the immune response. To study the influence of carriage of 8.1AH on frequency and onset of colonization in CF patients, DNA samples of 72 CF patients (39 homozygous and 33 heterozygous for DeltaF508) were genotyped for member alleles of the 8.1AH: HLA-DQB1*0201, HLA-DRB1*0301, receptor for advanced glycation end products (AGER) -429C, HSP70-2 -1267G (HSP70-2G) and tumor necrosis factor-alpha (TNF-alpha) -308A (TNF2). Colonization was verified by regular clinical and bacteriological screening. Frequency of colonization was significantly (P = 0.012) lower in the 8.1AH carriers; age, gender and DeltaF508 genotype-adjusted odds ratio to be colonized of the carriers versus non-carriers was 0.112 (0.024-0.520). According to survival analysis, patients with 8.1AH had significantly (P < 0.0001) longer colonization-free period compared with non-carriers. Our novel observations demonstrate that the 8.1AH is associated with delayed onset of colonization in CF, presumably by influencing defense mechanisms against infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987934     DOI: 10.1093/intimm/dxl091

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  17 in total

1.  Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.

Authors:  Jonas C Schupp; Sara Khanal; Jose L Gomez; Maor Sauler; Taylor S Adams; Geoffrey L Chupp; Xiting Yan; Sergio Poli; Yujiao Zhao; Ruth R Montgomery; Ivan O Rosas; Charles S Dela Cruz; Emanuela M Bruscia; Marie E Egan; Naftali Kaminski; Clemente J Britto
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

2.  Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypes.

Authors:  Wanda K O'Neal; Paul Gallins; Rhonda G Pace; Hong Dang; Whitney E Wolf; Lisa C Jones; XueLiang Guo; Yi-Hui Zhou; Vered Madar; Jinyan Huang; Liming Liang; Miriam F Moffatt; Garry R Cutting; Mitchell L Drumm; Johanna M Rommens; Lisa J Strug; Wei Sun; Jaclyn R Stonebraker; Fred A Wright; Michael R Knowles
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

3.  Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Deanna M Green; J Michael Collaco; Kathryn E McDougal; Kathleen M Naughton; Scott M Blackman; Garry R Cutting
Journal:  J Pediatr       Date:  2012-02-23       Impact factor: 4.406

4.  Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis.

Authors:  Thomas P Hofer; Marion Frankenberger; Irene Heimbeck; Dorothe Burggraf; Matthias Wjst; Adam K A Wright; Maria Kerscher; Susanne Nährig; Rudolf M Huber; Rainald Fischer; Loems Ziegler-Heitbrock
Journal:  J Mol Med (Berl)       Date:  2014-08-23       Impact factor: 4.599

5.  TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis.

Authors:  Faraz Bishehsari; Arun Sharma; Kimberly Stello; Chad Toth; Michael Richard O'Connell; Anna C Evans; Jessica LaRusch; Venkata Muddana; Georgios I Papachristou; David C Whitcomb
Journal:  Pancreatology       Date:  2012-02-25       Impact factor: 3.996

6.  Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation.

Authors:  Hong Dang; Deepika Polineni; Rhonda G Pace; Jaclyn R Stonebraker; Harriet Corvol; Garry R Cutting; Mitchell L Drumm; Lisa J Strug; Wanda K O'Neal; Michael R Knowles
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

7.  Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review.

Authors:  Syed H Haider; Assad Oskuei; George Crowley; Sophia Kwon; Rachel Lam; Jessica Riggs; Mena Mikhail; Angela Talusan; Arul Veerappan; James S Kim; Erin J Caraher; Anna Nolan
Journal:  Eur Respir Rev       Date:  2019-03-27

Review 8.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

9.  AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis.

Authors:  Julie Beucher; Pierre-Yves Boëlle; Pierre-François Busson; Céline Muselet-Charlier; Annick Clement; Harriet Corvol
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.